Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CLINICAL STUDY

NEJM Evidence

Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer

Oncology, Medical July 3rd 2023

Cancer Therapy Advisor

Acalabrutinib Plus Rituximab “Highly Effective” in Older MCL Patients

Hematology/Oncology July 3rd 2023

Medical Professionals Reference (MPR)

Allopurinol May Cut Risk for Neurodegenerative Diseases

Clinical Pharmacology June 30th 2023

The New England Journal of Medicine

Cardiovascular Safety of Testosterone-Replacement Therapy

Cardiology June 29th 2023

Psychiatrist.com

Study Tackles the Mystery of Brain Zaps in Antidepressant Withdrawal

Psychiatry June 28th 2023

Practical Neurology

Significant Differences in Therapy Discontinuation Rates Seen in Study of CBRP mAbs and Botox to Treat Migraine

Neurology June 28th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form